Novo Nordisk plunges after shock 2026 forecast

Zealand Pharma A/S

04/02/2026 08:31

Adds share moves, milestones, analyst comments

** Shares in Novo Nordisk NOVOb.CO tumble 16.5% after the Wegovy drug maker said on Wednesday it expects it sales and operating profit in 2026 to fall year on year

** The Danish pharma group forecasts its adjusted operating profit and sales at constant exchange rates to fall by 5%-13% in 2026

** At the midpoint the guidance implies sales and adjusted operating profit in the year around 8% and 9% below consensus, respectively, J.P. Morgan says

** "The range should be seen as uncertainty about the dynamics of the obesity market", Jyske Bank notes

** Novo fell as much as 19.5% on Wednesday, wiping as much as $50.6 bln off its market cap

** Novo peer Zealand Pharma ZELA.CO down 5%

 (Reporting by Boleslaw Lasocki)

 ((boleslaw.lasocki@thomsonreuters.com; +48 58 769 66 00;))